يعرض 1 - 20 نتائج من 297 نتيجة بحث عن '"Furie, R"', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 1
    Academic Journal
    DISTINCT PERIPHERAL IMMUNOPHENOTYPING UNDERLINES HISTOPATHOLOGICAL FEATURES IN PATIENTS WITH LUPUS NEPHRITIS IN A LARGE MULTI-CENTER COHORT

    المؤلفون: Horisberger, A, Griffith, A, Keegan, J, Howard, K, Pulford, J, Murzin, E, Hancock, B, Ghosh, T, Sasaki, T, Fava, A, Arcelus, M Gutierrez, Eisenhaure, T, Guthridge, J, Arazi, A, Hoover, P, Dall'era, M, Wofsy, D, Kamen, DL, Kalunian, K, Furie, R, Belmont, HM, Izmirly, P, Clancy, R, Hildeman, D, Woodle, ES, Apruzzese, W, Mcmahon, M, Grossman, J, Barnas, J, Payan-Schober, F, Ishimori, M, Weisman, M, Kretzler, M, Berthier, C, Hodgin, J, Putterman, C, Hacohen, N, Brenner, M, Anolik, JH, Davidson, A, James, JA, Raychaudhuri, S, Petri, MA, Buyon, J, Diamond, B, Amp, TAMPRN, Zhang, F, Lederer, J, Rao, D

    مصطلحات موضوعية: Kidneys, -Omics, Systemic lupus erythematosus, Clinical Sciences, Immunology, Public Health and Health Services, Arthritis & Rheumatology, Clinical sciences

    وصف الملف: application/pdf

    URL الوصول: https://escholarship.org/uc/item/15f6c70g

    View record in eScholarship

    أضف إلى المفضلة
  2. 2
    Academic Journal
    A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

    المؤلفون: Furie, R, Petri, M, Zamani, O, Cervera, R, Wallace, DJ, Tegzova, D, Sanchez-Guerrero, J, Schwarting, A, Merrill, JT, Chatham, WW, Stohl, W, Ginzler, EM, Hough, DR, Zhong, ZJ, Freimuth, W, van Vollenhoven, RF

    المصدر: Arthritis and rheumatism. 63(12):3918-3930

    مصطلحات موضوعية: Medicin och hälsovetenskap

    URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:123662820

    View record in SwePub Full Text Finder

    أضف إلى المفضلة
  3. 3
    Academic Journal
    AB0531 APPLYING THE WORKING DEFINITION OF THE DISEASE MODIFICATION CRITERIA TO LUPUS NEPHRITIS TREATMENTS FROM THE PUBLISHED LITERATURE

    المؤلفون: Askanase, A., Furie, R., Dall'era, M., Bomback, A., Schwarting, A., Zhao, M.H., Bruce, I.N., Khamashta, M., Rubin, B., Carroll, A., Daniels, M., Levy, R., Van Vollenhoven, R., Urowitz, M.B.

    المصدر: Annals of the Rheumatic Diseases ; volume 82, page 1463-1464 ; ISSN 0003-4967

    الاتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.3897
    https://api.elsevier.com/content/article/PII:S0003496724654750?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S0003496724654750?httpAccept=text/plain
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.3897

    View record in BASE

    أضف إلى المفضلة
  4. 4
    Academic Journal
    AB0530 DESIGN OF 2 PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, GLOBAL TRIALS OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 (TYK2) INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS

    المؤلفون: Arriens, C., Askanase, A., Furie, R., Morand, E.F., Van Vollenhoven, R., Connors, K., Davey, M., Delev, N., Shah, V., Stevens, A., Wegman, T., Hobar, C.

    المصدر: Annals of the Rheumatic Diseases ; volume 82, page 1463 ; ISSN 0003-4967

    الاتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.3881
    https://api.elsevier.com/content/article/PII:S0003496724654749?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S0003496724654749?httpAccept=text/plain
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.3881

    View record in BASE

    أضف إلى المفضلة
  5. 5
    Academic Journal
    OP0140 REGULATORY T CELL DEFECTS IN SLE AND THERAPY WITH A NOVEL IL-2 MUTEIN: PHASE 1 CLINICAL RESULTS WITH EFAVALEUKIN ALFA

    المؤلفون: Sarkar, N., Hu, X., Tchao, N., Furie, R., Kivitz, A., Cohen, S., Gorski, K.

    المصدر: Annals of the Rheumatic Diseases ; volume 82, page 92-93 ; ISSN 0003-4967

    الاتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.369
    https://api.elsevier.com/content/article/PII:S0003496724635958?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S0003496724635958?httpAccept=text/plain
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.369

    View record in BASE

    أضف إلى المفضلة
  6. 6
    Academic Journal
    POS1153 APPLYING THE WORKING DEFINITION OF THE DISEASE MODIFICATION CRITERIA TO SYSTEMIC LUPUS ERYTHEMATOSUS TREATMENTS FROM THE PUBLISHED LITERATURE

    المؤلفون: Askanase, A., Furie, R., Dall'era, M., Bomback, A., Schwarting, A., Zhao, M.H., Bruce, I.N., Khamashta, M., Rubin, B., Carroll, A., Daniels, M., Levy, R., Van Vollenhoven, R., Urowitz, M.B.

    المصدر: Annals of the Rheumatic Diseases ; volume 82, page 907-908 ; ISSN 0003-4967

    الاتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.3052
    https://api.elsevier.com/content/article/PII:S0003496724646728?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S0003496724646728?httpAccept=text/plain
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.3052

    View record in BASE

    أضف إلى المفضلة
  7. 7
    Academic Journal
    AB0518 EFFECT OF LITIFILIMAB ON TYPE I INTERFERON (IFN) BIOMARKERS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) OR CUTANEOUS LUPUS ERYTHEMATOSUS (CLE): RESULT OF THE LILAC PHASE 2 STUDY

    المؤلفون: Furie, R., Werth, V., Milliman, E., Ferber, K., Casey, F., Brown, R., Raitcheva, D., Zoghbi, J., Graham, D., Kong, G., Lahoud, Y., Franchimont, N., Barbey, C.

    المصدر: Annals of the Rheumatic Diseases ; volume 82, page 1453-1454 ; ISSN 0003-4967

    الاتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.2704
    https://api.elsevier.com/content/article/PII:S000349672465466X?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S000349672465466X?httpAccept=text/plain
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.2704

    View record in BASE

    أضف إلى المفضلة
  8. 8
    Academic Journal
    OP0186 DISTINCT PERIPHERAL IMMUNOPHENOTYPING UNDERLINES HISTOPATHOLOGICAL FEATURES IN PATIENTS WITH LUPUS NEPHRITIS IN A LARGE MULTI-CENTER COHORT

    المؤلفون: Horisberger, A., Griffith, A., Keegan, J., Howard, K., Pulford, J., Murzin, E., Hancock, B., Ghosh, T., Sasaki, T., Fava, A., Gutierrez Arcelus, M., Eisenhaure, T., Guthridge, J., Arazi, A., Hoover, P., Dall'era, M., Wofsy, D., Kamen, D.L., Kalunian, K., Furie, R., Belmont, H.M., Izmirly, P., Clancy, R., Hildeman, D., Woodle, E.S., Apruzzese, W., Mcmahon, M., Grossman, J., Barnas, J., Payan-Schober, F., Ishimori, M., Weisman, M., Kretzler, M., Berthier, C., Hodgin, J., Putterman, C., Hacohen, N., Brenner, M., Anolik, J.H., Davidson, A., James, J.A., Raychaudhuri, S., Petri, M.A., Buyon, J., Diamond, B., (Amp), T.A.M.P.R.N., Zhang, F., Lederer, J., Rao, D.

    المصدر: Annals of the Rheumatic Diseases ; volume 82, page 122-123 ; ISSN 0003-4967

    الاتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.2265
    https://api.elsevier.com/content/article/PII:S0003496724636319?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S0003496724636319?httpAccept=text/plain
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.2265

    View record in BASE

    أضف إلى المفضلة
  9. 9
    Academic Journal
    POS0115 DAPIROLIZUMAB PEGOL EFFICACY BY SUBGROUPS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A POST HOC ANALYSIS OF PHASE 2 CLINICAL TRIAL DATA

    المؤلفون: Askanase, A., Stach, C., Brittain, C., Stojan, G., Furie, R.

    المصدر: Annals of the Rheumatic Diseases ; volume 82, page 272-273 ; ISSN 0003-4967

    الاتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.1991
    https://api.elsevier.com/content/article/PII:S0003496724638306?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S0003496724638306?httpAccept=text/plain
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.1991

    View record in BASE

    أضف إلى المفضلة
  10. 10
    Academic Journal
    OP0051 LUPUS LOW DISEASE ACTIVITY STATE ATTAINMENT IN THE PHASE 3 PLACEBO-CONTROLLED TULIP LONG-TERM EXTENSION TRIAL OF ANIFROLUMAB

    المؤلفون: Morand, E.F., Van Vollenhoven, R., Furie, R., Kalunian, K., Yavuz, S., Abreu, G., Lindholm, C., Al-Mossawi, H.

    المصدر: Annals of the Rheumatic Diseases ; volume 82, page 33-34 ; ISSN 0003-4967

    الاتاحة: https://doi.org/10.1136/annrheumdis-2023-eular.1568
    https://api.elsevier.com/content/article/PII:S0003496724635302?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S0003496724635302?httpAccept=text/plain
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.1568

    View record in BASE

    أضف إلى المفضلة
  11. 11
    Conference
    PO.5.105 The effect of belimumab on extra-renal outcomes: results from the phase 3, randomised, placebo-controlled, 104-week bliss-ln study in patients with active lupus nephritis

    المؤلفون: Weinmann-Menke, J, Okada, M, Arriens, C, Jones-Leone, A, Levy, RA, Gilbride, JA, Furie, R, Yang, N

    المصدر: Friday 07 October 2022 from 13:00 to 14:10 ; page A83-A84

    الاتاحة: http://dx.doi.org/10.1136/lupus-2022-elm2022.129
    https://syndication.highwire.org/content/doi/10.1136/lupus-2022-elm2022.129

    View record in BASE

    أضف إلى المفضلة
  12. 12
    Conference
    PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

    المؤلفون: Tchao, N, Sarkar, N, Hu, X, Zhang, R, Milmont, C, Shi Jin, Y, Chow, V, Kroenke, M, Gorski, K, Furie, R, Alan, K, Stanley, C

    المصدر: Friday 07 October 2022 from 13:00 to 14:10 ; page A96-A97

    الاتاحة: http://dx.doi.org/10.1136/lupus-2022-elm2022.148
    https://syndication.highwire.org/content/doi/10.1136/lupus-2022-elm2022.148

    View record in BASE

    أضف إلى المفضلة
  13. 13
    Academic Journal
    Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis

    المؤلفون: Fava A., Buyon J., Magder L., Hodgin J., Rosenberg A., Demeke D. S., Rao D. A., Arazi A., Celia A. I., Putterman C., Anolik J. H., Barnas J., Dall'Era M., Wofsy D., Furie R., Kamen D., Kalunian K., James J. A., Guthridge J., Atta M. G., Trujillo J. M., Fine D., Clancy R., Belmont H. M., Izmirly P., Apruzzese W., Goldman D., Berthier C. C., Hoover P., Hacohen N., Raychaudhuri S., Davidson A., Diamond B., Petri M.

    المساهمون: Fava, A., Buyon, J., Magder, L., Hodgin, J., Rosenberg, A., Demeke, D. S., Rao, D. A., Arazi, A., Celia, A. I., Putterman, C., Anolik, J. H., Barnas, J., Dall'Era, M., Wofsy, D., Furie, R., Kamen, D., Kalunian, K., James, J. A., Guthridge, J., Atta, M. G., Trujillo, J. M., Fine, D., Clancy, R., Belmont, H. M., Izmirly, P., Apruzzese, W., Goldman, D., Berthier, C. C., Hoover, P., Hacohen, N., Raychaudhuri, S., Davidson, A., Diamond, B., Petri, M.

    مصطلحات موضوعية: Autoimmunity, Diagnostic, Lupu, Nephrology, Proteomics

    Relation: info:eu-repo/semantics/altIdentifier/pmid/38258904; info:eu-repo/semantics/altIdentifier/wos/WOS:001165983900001; volume:9; issue:2; journal:JCI INSIGHT; https://hdl.handle.net/11573/1726823

    الاتاحة: https://hdl.handle.net/11573/1726823
    https://doi.org/10.1172/jci.insight.172569

    View record in BASE

    أضف إلى المفضلة
  14. 14
    Conference
    POS0541 GLUCOCORTICOID REDUCTION AND WITHDRAWAL IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS RECEIVING LONG-TERM ANIFROLUMAB TREATMENT

    المؤلفون: Furie, R. A., Bruce, I. N., Kalunian, K. C., Morand, E., Manzi, S., Tanaka, Y., Knagenhjelm, J., Tummala, R., Lindholm, C.

    المصدر: Scientific Abstracts ; page 958.2-959

    الاتاحة: https://doi.org/10.1136/annrheumdis-2024-eular.1401
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2024-eular.1401

    View record in BASE

    أضف إلى المفضلة
  15. 15
    Conference
    POS0528 LUPUS LOW DISEASE ACTIVITY STATE ATTAINMENT AND REDUCED GLUCOCORTICOID USE IN PATIENTS WITH SLE IN THE TULIP LONG-TERM EXTENSION TRIAL OF ANIFROLUMAB

    المؤلفون: Morand, E., Van Vollenhoven, R. F., Furie, R. A., Bruce, I. N., Tanaka, Y., Knagenhjelm, J., Hultquist, M., Tummala, R., Lindholm, C.

    المصدر: Scientific Abstracts ; page 958.1-958

    الاتاحة: https://doi.org/10.1136/annrheumdis-2024-eular.1393
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2024-eular.1393

    View record in BASE

    أضف إلى المفضلة
  16. 16
    Conference
    OP0077 LONGITUDINAL ASSESSMENT OF BIOMARKERS IN NOBILITY, A RANDOMIZED, PHASE II CLINICAL TRIAL OF OBINUTUZUMAB FOR TREATMENT OF PROLIFERATIVE LUPUS NEPHRITIS

    المؤلفون: Vital, E. M., Tas, S. W., Malvar, A., Looney, C. M., Raghu, H., Anania, V. G., Mao, H. A., Wang, T., Williams, S., Schindler, T., Martins, E., Ross Terres, J. A., Pendergraft, W. F., Furie, R. A.

    المصدر: Scientific Abstracts ; page 140.1-140

    الاتاحة: http://dx.doi.org/10.1136/annrheumdis-2024-eular.1317
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2024-eular.1317

    View record in BASE

    أضف إلى المفضلة
  17. 17
    Conference
    POS1405 IDENTIFICATION OF SPATIALLY-RESOLVED IMMUNE POPULATIONS IN LUPUS NEPHRITIS KIDNEY VIA HI-RESOLUTION 20-PLEX IMMUNOHISTOCHEMISTRY SINGLE-CELL SPATIAL ANALYSES

    المؤلفون: Marlin, M. C., Lee, C. Y., Yang, X., Stephens, T., Celia, A. I., Wright, C., Hodgin, J., Izmirly, P., Belmont, H. M., Furie, R., Anolik, J. H., James, J. A., Petri, M., Buyon, J. P., Kamen, D. L., Putterman, C., Fava, A., Rosenberg, A., Guthridge, J. M.

    المصدر: Scientific Abstracts ; page 943-944

    الاتاحة: https://doi.org/10.1136/annrheumdis-2024-eular.6143
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2024-eular.6143

    View record in BASE

    أضف إلى المفضلة
  18. 18
    Conference
    POS0529 OBINUTUZUMAB BENEFITS PATIENTS WITH ACTIVE LUPUS NEPHRITIS IRRESPECTIVE OF BASELINE PROTEINURIA SEVERITY: A POST HOC ANALYSIS OF THE PHASE II NOBILITY TRIAL

    المؤلفون: Furie, R. A., Ross Terres, J. A., Martins, E., Hassan, I., Schindler, T., Garg, J. P., Pendergraft, W. F., Malvar, A., Rovin, B. H.

    المصدر: Scientific Abstracts ; page 961.1-961

    الاتاحة: https://doi.org/10.1136/annrheumdis-2024-eular.1543
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2024-eular.1543

    View record in BASE

    أضف إلى المفضلة
  19. 19
    Conference
    POS0542 EFFICACY OF DEUCRAVACITINIB, A FIRST-IN-CLASS, ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 INHIBITOR, IN MUSCULOSKELETAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS: A SUBANALYSIS OF THE PHASE 2 PAISLEY STUDY

    المؤلفون: Pike, M., Saxena, A., Furie, R. A., Nash, P., Dörner, T., Hobar, C., Pomponi, S., Koti, R., Banerjee, S., Wegman, T., Merrill, J.

    المصدر: Scientific Abstracts ; page 960-960

    الاتاحة: https://doi.org/10.1136/annrheumdis-2024-eular.1522
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2024-eular.1522

    View record in BASE

    أضف إلى المفضلة
  20. 20
    Academic Journal
    AB0425 WHAT DOES IT MEAN TO BE A DUAL BICLA AND SRI(4) RESPONDER? A POOLED ANALYSIS OF TWO PHASE 3 TRIALS IN PATIENTS WITH SLE

    المؤلفون: Bruce, I.N., Psachoulia, K., Maho, E., Isenberg, D., van Vollenhoven, R., Furie, R., Morand, E.F., Lindholm, C., Hultquist, M., Tummala, R.

    المصدر: Annals of the Rheumatic Diseases ; volume 81, page 1340-1341 ; ISSN 0003-4967

    الاتاحة: https://doi.org/10.1136/annrheumdis-2022-eular.900
    https://api.elsevier.com/content/article/PII:S0003496724288555?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S0003496724288555?httpAccept=text/plain
    https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2022-eular.900

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء